COVID-19 : les soignants sont-ils de véritables super-héros ?
E. Breugnon(Centre Hospitalier Universitaire de Saint-Étienne), Amandine Gagneux‐Brunon(Centre Hospitalier Universitaire de Saint-Étienne), H. Thollot(Centre Hospitalier Universitaire de Saint-Étienne), Sylvie Pillet(Centre Hospitalier Universitaire de Saint-Étienne), P. Berthelot(Hôpital Beaujon), Rémi Labetoulle(Centre Hospitalier Universitaire de Saint-Étienne), F. Saunier(Centre Hospitalier Universitaire de Saint-Étienne), Élisabeth Botelho-Nevers(Université Claude Bernard Lyon 1), F. Lucht(Centre Hospitalier Universitaire de Saint-Étienne), Antoine Fraissenon(Université Claude Bernard Lyon 1)
Cited by 0
Related Papers
Arterial Changes in the Lungs in Cirrhosis of the Liver — Lung Spider Nevi
|New England Journal of Medicine|1966|356
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
|Clinical Microbiology and Infection|2021|107
Estrogen Permits Vasopressin Signaling in Preoptic Kisspeptin Neurons in the Female Mouse
|Journal of Neuroscience|2015|94
Alpelisib administration reduced lymphatic malformations in a mouse model and in patients
|Science Translational Medicine|2021|92